THE INVOLVEMENT OF NORADRENALINE, 5-HYDROXYTRYPTAMINE AND ACETYLCHOLINE IN IMIPRAMINE-INDUCED SEIZURES IN MICE

被引:8
作者
AMABEOKU, GJ
机构
[1] Department of Clinical Pharmacology, Medical School, University of Zimbabwe, Harare, Avondale
来源
EXPERIENTIA | 1993年 / 49卷 / 10期
关键词
IMIPRAMINE; SEIZURES; NORADRENERGIC; SEROTONINERGIC AND CHOLINERGIC MECHANISMS;
D O I
10.1007/BF01952598
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The influence of some noradrenergic, 5-hydroxytryptaminergic and cholinergic agents on imipramine-induced seizures were investigated in mice. DL-threo-3,4-dihydroxyphenylserine (DOPS) and pargyline significantly potentiated imipramine-induced seizures. Phentolamine and prazosin significantly attenuated seizures elicited by imipramine and significantly attenuated the seizure-enhancing effect of DOPS. Alpha-Methyl-p-tyrosine and reserpine significantly attenuated seizures induced by imipramine. Disulfiram significantly protected mice against imipramine-induced seizures. However, DOPS significantly potentiated seizures induced by imipramine in disulfiram-pretreated animals. Clonidine effectively protected mice against imipramine-induced seizures. Idazoxan, on the other hand, significantly protentiated seizures induced by imipramine and significantly antagonised the protective effect of clonidine against the seizures. 5-HTP, PCPA, cyproheptadine, mianserin, ketanserin and trazodone did not affect imipramine-induced seizures to any significant extent. Physostigmine antagonised seizures induced by imipramine while atropine significantly potentiated the seizures, and significantly attenuated the protective effect of physostigmine against the seizures. These data suggest that enhancement and attenuation of central noradrenergic and cholinergic neurotransmissions respectively, and not 5-HT mechanisms, may underlie imipramine-induced seizures in mice.
引用
收藏
页码:859 / 864
页数:6
相关论文
共 33 条
[1]  
Amabeoku G J, 1993, Eur Neuropsychopharmacol, V3, P37, DOI 10.1016/0924-977X(93)90293-U
[2]  
BLASCHKO H, 1958, J PHARMACOL EXP THER, V122, P182
[3]  
BOGDANSKI DF, 1958, J PHARMACOL EXP THER, V122, P182
[4]   TRICYCLIC ANTIDEPRESSANT POISONING - REVERSAL OF COMA, CHOREOATHETOSIS, AND MYOCLONUS BY PHYSOSTIGMINE [J].
BURKS, JS ;
WALKER, JE ;
RUMACK, BH ;
OTT, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (10) :1405-1407
[5]   PROBLEM OF TRICYCLIC ANTI-DEPRESSANT POISONING [J].
CROME, P ;
NEWMAN, B .
POSTGRADUATE MEDICAL JOURNAL, 1979, 55 (646) :528-532
[6]  
DESCHAEPDRYVER AF, 1962, ARCH INT PHARMACOD T, V140, P358
[7]   STUDIES ON RX781094 - A SELECTIVE, POTENT AND SPECIFIC ANTAGONIST OF ALPHA-2-ADRENOCEPTORS [J].
DOXEY, JC ;
ROACH, AG ;
SMITH, CFC .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 78 (03) :489-505
[8]   PRELIMINARY-REPORT ON IMIPRAMINE (TOFRANIL) [J].
FELDMAN, PE .
AMERICAN JOURNAL OF PSYCHIATRY, 1959, 115 (12) :1117-1118
[9]  
FLATTERY KV, 1985, PRINCIPLES MED PHARM, P203
[10]  
FLETCHER A, 1984, British Journal of Pharmacology, V81, p39P